Evidence map›Paper›PMID 12805214›Full record

ArticleThe EMBO journal2003

Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation.

Andrei A Sharov, Lorin Weiner, Tatyana Y Sharova, Frank Siebenhaar, Ruzanna Atoyan, Anthony M Reginato, Coleen A McNamara, Keiko Funa, Barbara A Gilchrest, Janice L Brissette and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Andrei A SharovDepartment of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118, USA.
Lorin Weiner
Tatyana Y Sharova
Frank Siebenhaar
Ruzanna Atoyan
Anthony M Reginato
Coleen A McNamara
Keiko Funa
Barbara A Gilchrest
Janice L Brissette
Vladimir A Botchkarev
Boston University · US

Funding

Mouse nude locus and skin developmentR01AR045284 · NIAMS · SUNY DOWNSTATE MEDICAL CENTER · PI BRISSETTE, JANICE L · 1998 to 2013
$4.2M
FUNCTIONS OF NOGGIN AND SMAD1/5 IN HAIR GROWTH CONTROLR01AR049778 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOTCHKAREV, VLADIMIR A · 2004 to 2014
$3.5M
ACTIVIN RECEPTORS AND SMAD2 IN MAMMALIAN GASTRULATIONR01HD035286 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI BRISSETTE, JANICE L · 1999 to 2003
$1.0M
FUNCTION OF NOGGIN IN HAIR FOLLICLE GROWTH AND DISEASEK02AR048573 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOTCHKAREV, VLADIMIR A · 2002 to 2006
$488k
A ROLE FOR NOGGIN AND BMP2/4 IN HAIR GROWTH CONTROLR03AR047414 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOTCHKAREV, VLADIMIR A · 2001 to 2003
$245k
NIAMS NIH HHS AR45284NIAMS NIH HHS AR47414NIAMS NIH HHS AR48573NIAMS NIH HHS K02 AR048573NIAMS NIH HHS R01 AR045284NIAMS NIH HHS R03 AR047414
6 · The paper itself

Abstract

Contact of developing sensory organs with the external environment is established via the formation of openings in the skin. During eye development, eyelids first grow, fuse and finally reopen, thus providing access for visual information to the retina. Here, we show that eyelid opening is strongly inhibited in transgenic mice overexpressing the bone morphogenetic protein (BMP) antagonist noggin from the keratin 5 (K5) promoter in the epidermis. In wild-type mice, enhanced expression of the kinase-inactive form of BMPR-IB mediated by an adenovirus vector also inhibits eyelid opening. Noggin overexpression leads to reduction of apoptosis and retardation of cell differentiation in the eyelid epithelium, which is associated with downregulation of expression of the apoptotic receptors (Fas, p55 kDa TNFR), Id3 protein and keratinocyte differentiation markers (loricrin, involucrin). BMP-4, but not EGF or TGF-alpha, accelerates opening of the eyelid explants isolated from K5-Noggin transgenic mice when cultured ex vivo. These data suggest that the BMP signaling pathway plays an important role in regulation of genetic programs of eyelid opening and skin remodeling during the final steps of eye morphogenesis.

Indexed as

Epidermal CellsAdenoviridaeAnimalsApoptosisBiomarkersBone Morphogenetic Protein ReceptorsBone Morphogenetic ProteinsCarrier ProteinsCell DifferentiationCulture TechniquesDNA-Binding ProteinsEmbryo, MammalianEpidermal Growth FactorEpidermisEyelidsGenetic VectorsBiomarkersBone Morphogenetic Protein ReceptorsBone Morphogenetic ProteinsCarrier ProteinsDNA-Binding ProteinsEpidermal Growth FactorGDF5 protein, humanGdf5 protein, mouseGrowth Differentiation Factor 5Keratin-15Keratin-5KeratinsKrt15 protein, mouseKRT5 protein, humanNeoplasm ProteinsNoggin ProteinProteinsReceptors, Growth FactorSmad ProteinsTrans-ActivatorsTransforming Growth Factor alpha

Identifiers

PMID12805214
PMCPMC162143
OpenAlexW2135988581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.